ACH
ATRA icon

ArrowMark Colorado Holdings’s Atara Biotherapeutics ATRA Stock Holding History

ArrowMark Colorado Holdings’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,027
Closed -$1.02M – 318
2019
Q2 		$1.02M Sell
2,027
-55
-3% -$38.8K 0.01% 277
2019
Q1 		$2.07M Sell
2,082
-57,561
-97% -$53.5M 0.02% 244
2018
Q4 		$51.8M Sell
59,643
-469
-0.8% -$436K 0.54% 64
2018
Q3 		$62.1M Buy
60,112
+9,872
+20% +$9.65M 0.52% 63
2018
Q2 		$46.2M Sell
50,240
-7,161
-12% -$7.69M 0.42% 86
2018
Q1 		$56M Sell
57,401
-68,472
-54% -$62.4M 0.56% 65
2017
Q4 		$57M Buy
125,873
+14,844
+13% +$5.48M 0.58% 63
2017
Q3 		$45.9M Buy
111,029
+27,708
+33% +$10.4M 0.52% 66
2017
Q2 		$29.2M Buy
83,321
+6,060
+8% +$2.33M 0.36% 89
2017
Q1 		$39.7M Buy
77,261
+14,837
+24% +$6.14M 0.54% 65
2016
Q4 		$22.2M Buy
62,424
+9,611
+18% +$4.07M 0.35% 89
2016
Q3 		$28.2M Buy
52,813
+2,681
+5% +$1.46M 0.51% 68
2016
Q2 		$28.2M Buy
50,132
+16,130
+47% +$7.74M 0.57% 60
2016
Q1 		$16.2M Buy
34,002
+4,541
+15% +$2.04M 0.36% 87
2015
Q4 		$19.5M Buy
29,461
+10,563
+56% +$7.99M 0.53% 64
2015
Q3 		$14.9M Buy
18,898
+13,951
+282% +$17M 0.41% 76
2015
Q2 		$6.53M Buy
4,947
+62
+1% +$71.1K 0.16% 132
2015
Q1 		$5.08M Buy
+4,885
New +$3.23M 0.13% 140

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ArrowMark Colorado Holdings's ATRA Position: Q3 2019 in Review

ArrowMark Colorado Holdings sold out of Atara Biotherapeutics (ATRA) in Q3 2019, closing a stake of 2,027 shares — an estimated $1.02M sold.

ArrowMark Colorado Holdings first reported a position in ATRA in Q1 2015 and held it in 18 quarters. The position peaked at $62.1M in Q3 2018. 112 funds tracked by Wall St. Rank hold ATRA as of Q3 2019.

  • ArrowMark Colorado Holdings reported no remaining Atara Biotherapeutics position as of Q3 2019 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 2,027 Atara Biotherapeutics shares in Q3 2019, an estimated $1.02M.
  • ArrowMark Colorado Holdings first reported a position in Atara Biotherapeutics in Q1 2015 and held it in 18 quarters.
  • ArrowMark Colorado Holdings's Atara Biotherapeutics position peaked at $62.1M in Q3 2018.
  • 112 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q3 2019.

Based on ArrowMark Colorado Holdings's 13F filing for Q3 2019, filed 14 Nov 2019.